NCT06177561View on ClinicalTrials.gov

Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT

NARecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2025

Conditions
Leukemia
Interventions
PROCEDURE

Lymphoplasma exchange

The LPE treatment regimen is: LPE\*2 times (20-30ml/kg, treatment interval of 2 days);CD20 monoclonal antibody 375mg/m2\*2 times, gamma globulin 0.4g/kg/d\*5d.

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER